In the latest move towards finding a stem cell-based cure for type 1 diabetes, Vertex announced a new agreement with CRISPR Therapeutics. This allows Vertex to use...

Novo Nordisk’s PIONEER PLUS trial has delivered promising A1C and weight loss results for patients with type 2 diabetes taking the oral semaglutide Rybelsus at...

In case you missed them, below you’ll find our top stories from March 2023. This month’s best stories cover a wide variety of topics including a preview of upcoming...

Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop...

A clinical trial is recruiting participants with type 2 diabetes and chronic kidney disease (CKD) to see how well a combination of glucose-lowering and kidney-...

Triglycerides—a type of fat that circulates in the blood along with cholesterol—can be a risk factor for developing diabetes. If you have diabetes, monitoring...

The Centers for Medicare and Medicaid Services has created a Special Enrollment Period for people with insulin to change their Part D coverage and ensure they are not...

People with diabetes can’t access glucose data in the water, which adds complexity to blood glucose management in a sport like endurance swimming. A long distance-...

Managing diabetes is a full-time juggling act, and doing so while living with anxiety and depression can make it even harder. Hear from people with diabetes and...

For people with diabetes who require dialysis, there are a growing number of options for treatment.

The U.S. News & World Report recently released its 2023 list of the best diets for people with diabetes. See which diets made the list, and the benefits and...

Following Eli Lilly’s recent announcement of a $35 monthly limit on out-of pocket costs, Sanofi announced a $35 cost cap on Lantus, and Novo Nordisk pledged to reduce...

How does technology shape the experiences of those with diabetes? From access to healthcare to data collection, the advances of the digital age have left a...

Randall Barker, who has had type 1 diabetes for over 30 years and lost his vision, shares lessons learned with Emma, his teenage daughter with type 1 diabetes, about...

In the US, it is estimated that 8.5 million people are unaware that they have T2D, which can lead to serious health problems. A new research project addressed this...

The language we use to talk to people with diabetes, and about diabetes in general, can have a real impact. But are scientific and academic publications doing their...

You have probably heard of time in range (TIR), but time in tight range (TITR) has slowly become popular among some diabetes experts. Whereas guidelines generally...

The FDA announced that a new type 1 diabetes stem cell therapy from Vertex has been cleared to enter clinical trials in the United States. The therapy, which hopes to...

The FDA has cleared Abbott's Freestyle Libre 2 and Libre 3 continuous glucose monitors (CGM) for integration with automated insulin delivery (AID) systems. These...

Do people with diabetes need to eat at regular intervals? Is late night snacking ok? What about intermittent fasting? Learn more about why timing matters when eating...

Learn more about the PsychoSocial Aspects of Diabetes (PSAD) Study Group and the professionals and people with diabetes making sure we prioritize more than just the...

In case you missed them, below you'll find our top five stories from February 2023. This month's best stories cover various topics including type 2 therapies, the...

Medicare will begin covering continuous glucose monitors (CGMs) for a broader group of T2D patients beginning in April.

Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%. The drug maker will also...

At diaTribe’s Solvable Problems event in Berlin, we heard from esteemed physicians about their thoughts on the use of technology among people with diabetes.

People with diabetes are at increased risk for heart disease. Cardiovascular disease is the leading cause of death in type 1 diabetes, and its burden is also...

At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA approved drugs, as well...

Researchers at the 2023 ATTD conference discussed research findings about hypoglycemia and potential solutions for resolving low blood sugar events.

Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge.

A closed-loop system enables your CGM to communicate with your insulin pump to adjust your insulin dosage throughout the day. Researchers at ATTD 2023 presented the...

New research from diaTribe and market research firm, dQ&A, is looking to explore how diabetes stigma might be impacting people’s willingness to use insulin pumps...

At the ATTD 2023 conference, panelists during the #dedocº Symposium highlighted how access and personalization impacts people with diabetes’ uptake and use of...

Researchers at the 2023 ATTD conference discussed the challenge of keeping up with insulin requirements in women with type 1 diabetes during pregnancy. After...

The low-cost drug verapamil, a widely available generic drug for blood pressure, was shown to preserve insulin-producing beta cell function in young people, aged 7-17...

Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...

On the opening morning of the ATTD 2023 conference, several leading clinicians from across Europe gathered to discuss the future of continuous glucose monitoring (CGM...

Every word in this article was written by ChatGPT (not a human). To create this article, we asked it questions about using ChatGPT in diabetes care. This article...

Leading clinicians at the ATTD conference discussed the need for greater CGM access for people with type 2 diabetes, as well as those with cystic fibrosis-related...

The diaTribe team is headed to Berlin, Germany, to cover this year’s Advanced Technologies and Treatments for Diabetes (ATTD) conference! Here’s a preview of some...

Fractyl Health, a company that has pioneered a procedure called Duodenal Mucosal Resurfacing, announced on Feb. 8 that it has begun offering its procedure as a type 2...

The parent of a teenager with type 1 diabetes shares her thoughts on calling someone "diabetic," as opposed to "person with diabetes," and why language matters when...

During his State of the Union Address on Feb. 7, President Joe Biden called on congress to expand the cap on monthly insulin prices to all people with diabetes....

It’s not always easy to talk about sex, regardless of whether you have diabetes or not. If you are a person living with diabetes, here are some important things to...

If you are an adult with type 1 or type 2 diabetes and live in the UK or US, take this short 10 minute survey to help researchers better understand the mental health...

During this year’s Super Bowl, Dexcom will air a commercial starring pop star Nick Jonas, announcing the US launch of its latest continuous glucose monitor (CGM), the...

The world’s hottest new miracle drug for type 2 diabetes, Ozempic (semaglutide), has surged in popularity among people with and without diabetes looking to lose...

Wanting to learn more about the impact that diabetes can have on someone’s love life, we asked people with diabetes about their successes as well as heartbreaks. We...

Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project...

diaTribe’s own Diane Scherer shares why she is both eager and hesitant as she navigates various diabetes devices over the years and offers tips for trying new...

Dexcom and Division I college athletes have teamed up to encourage other people living with diabetes to fully participate in sports.

The FDA approved Proclaim XR, a new implantable spinal cord stimulation device, as a treatment for pain from diabetes-related nerve damage, which affects 1 in 3...